August 12, 2020
Article
In individuals with type 1 diabetes (T1D), bacterial infections are associated with an increased risk of coronary heart disease, according to a study published in the Journal of Internal Medicine.
August 10, 2020
Article
Researchers developed a test to better determine which children will develop type 1 diabetes (T1D), moving closer to routine testing for newborns and potentially avoiding the risk of life-threatening complications.
August 05, 2020
Article
Results from a large population-based cohort study, published in Arthritis Care & Research, found individuals with rheumatoid arthritis (RA) had a lower rate of incident type 2 diabetes (T2D) compared with the general non-RA population and cohorts with with hypertension, osteoarthritis (OA), and psoriatic arthritis (PsA).
August 03, 2020
Article
Throughout the country, rising cases of coronavirus disease 2019 prove stressful for individuals most at risk of dying from the disease, including those with underlying conditions such as diabetes. Compounding this issue, new results from a study published in Psychoneuroendocrinology show the stress hormone cortisol is associated with higher blood sugar levels in individuals with type 2 diabetes (T2D), suggesting cortisol plays a detrimental role in contributing to glycemia in this population.
July 30, 2020
Article
Results for EMPEROR-Reduced have been highly anticipated, as they are expected to set off a new round of competition in the drug class, which was first developed to treat type 2 diabetes.
July 30, 2020
Article
Insulin cost-sharing caps may benefit children and young adults with type 1 diabetes (T1D), according to new research published in JAMA Pediatrics.
July 28, 2020
Article
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with an almost 3-fold increased risk of diabetic ketoacidosis (DKA) in some patients with type 2 diabetes (T2D), according to data from a retrospective cohort study published in Annals of Internal Medicine.
July 25, 2020
Article
The orders President Trump signed Friday include a deadline for the pharmaceutical industry to come up with their own plan by August 24 to lower prices.
July 24, 2020
Article
IQVIA, a health information technology and clinical research company, recently announced a new collaboration with JDRF, the world’s largest nonprofit funder of type 1 diabetes (T1D) research. Together, the companies plan to develop a real-world research platform to facilitate evidence generation for T1D via non-identified patient-level data and analytics.
July 21, 2020
Article
Children with type 1 diabetes (T1D) have a less desirable gut microbiome composition, potentially contributing to the development of the disease, according to new research published in the Journal of Clinical Endocrinology & Metabolism.